1983
DOI: 10.1136/bmj.287.6394.762-a
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxic drugs for non-neoplastic disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1993
1993
2020
2020

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 3 publications
0
2
0
Order By: Relevance
“…When the drug was stopped the pain regressed and the fracture healed. To our knowledge Ansell et al for the first time drew attention to the occurrence of stress fractures as a possible complication of MTX treatment for non-neoplastic diseases 8. Since then several case reports including patients treated for psoriasis and rheumatic diseases have been published 9-15…”
Section: Discussionmentioning
confidence: 99%
“…When the drug was stopped the pain regressed and the fracture healed. To our knowledge Ansell et al for the first time drew attention to the occurrence of stress fractures as a possible complication of MTX treatment for non-neoplastic diseases 8. Since then several case reports including patients treated for psoriasis and rheumatic diseases have been published 9-15…”
Section: Discussionmentioning
confidence: 99%
“…MTX is a cytotoxic drug commonly used at low dosage as a disease modifying drug in rheumatologic diseases, mainly in rheumatoid arthritis (RA) [2] and psoriasis [3]. A case of MTX induced osteopathy in rheumatology was firstly described in 1983, in a 72 years Caucasian man treated for widespread skin psoriasis and psoriatic arthritis; he developed spontaneously a stress fracture of the medial condyle of the right femur [4]. After this case, many cases, mostly isolated cases reports, were reported in the literature.…”
Section: Introductionmentioning
confidence: 99%